baber/WOPTO huggingface dataset:
Patent DE-69931275-T2 (DE)
Inventor: BLAZEY D
IPC: A23C19/045
Filed: 1999-11-08
Granted: 2007-05-24
Abstract: The invention relates to a simplified, rapid method which is suitable for making a variety of cheese and cheese products, including natural and processed cheese, in a single installation with common equipment. In particular, the invention concerns a method of making cheese, comprising the steps of: (a) concentrating milk or a reconstituted dry milk, having its pH adjusted to about 5.0 to 6.8, by ultrafiltration and diafiltration to produce a retentate; (b) supplementing said retentate with a protein concentrate or isolate and, optionally, fat and/or flavor; and (c) heating the mixture to produce a smooth consistency.
Patent DE-69932630-T2 (DE)
Inventor: BURIANNE YANNICK
IPC: G06F9/445
Filed: 1999-12-08
Granted: 2007-08-02
Abstract: This invention relates to an integrated circuit device comprising a memory and at least one application program residing within said memory. This invention is characterized in that the application program comprises at least one configurable variable and a list of at least one reference element, and in that said memory includes, on the one hand, at least one means for initializing said variables, wherein said means is configured with several parameters, one of which parameters is said reference element list, and on the other hand, a command for sending data that contain, in particular, values to be assigned to the configurable variables. This invention can be applied, in particular, to smart cards.
Patent DE-69935351-T2 (DE)
Inventor: DOERING KENNETH
IPC: H01J37/32
Filed: 1999-12-16
Granted: 2007-11-08
Abstract: A processing station adaptable to standard cluster tools has a vertically-translatable pedestal having an upper wafer-support surface including a heater plate adapted to be plugged into a unique feedthrough in the pedestal. At a lower position for the pedestal wafers may be transferred to and from the processing station, and at an upper position for the pedestal the pedestal forms an annular pumping passage with a lower circular opening in a processing chamber. A removable, replaceable ring at the lower opening of the processing chamber allows process pumping speed to be tailored for different processes by replacing the ring. In some embodiments the pedestal also has a surrounding shroud defining an annular pumping passage around the pedestal. A unique two-zone heater plate is adapted to the top of the pedestal, and connects to a unique feedthrough allowing heater plates to be quickly and simply replaced. In some embodiments the top of the processing chamber is removable allowing users to remove either pedestals or heater assemblies. Or both, through the open top of a processing station. In preferred embodiments the system is adapted to atomic layer deposition processing.
Patent DE-69938078-T2 (DE)
Inventor: BOHIN FABRICE
IPC: C08L83/07
Filed: 1999-02-24
Granted: 2009-01-22
Abstract: The invention concerns a cross-linkable adhesive silicone composition, and the use of said composition for bonding various substrates, comprising: a polyorganosiloxane (POS) with Si-Vi(polydimethylsiloxane alpha,omega-dj-Vi) units; a crosslinking POS with SiH units; a platinum catalyst; an adherence promoter comprising vinyltrimethoxysilane, 3-glycidoxy-propyltrimethoxysilane and buryl titanate; and optionally a filler and/or a cross linkage inhibitor and/or an unsaturated POS resin such as MMviDDviQ or MDviQ. The invention aims at providing a highly adhesive glue having, before setting, a low viscosity adapted for easy application on the substrates to be bonded. The invention achieves this by providing a cross-linkable adhesive silicone composition as defined above and characterised in that it has a peeling force Fp>=0.25 N/mm. a viscosity eta>=50.103mPa's at 25°, a tear resistance Rd>=6/mm (ASTM-624A) and a Shore hardness A>=35. The invention also concerns the use of said composition as adhesive.
Patent HU-E031410-T2 (HU)
Title: Window component scrap reduction
Inventor: MCGLINCHY TIMOTHY B
IPC: B21D53/74
Filed: 2005-09-15
Abstract: A method of making elongated spacer frame members prevents a first spacer frame member in a series of spacer frame members from being scrapped. A supply of thin relatively narrow sheet metal stock is provided. The stock is fed endwise to a stamping station. The stock is passed through the stamping station that stamps the stock to define a scrap length of stock followed by a connected first spacer frame defining length of stock. The scrap length of stock and the connected first spacer frame defining length of stock are fed to a roll forming station. The scrap length of stock and the connected first spacer frame defining length of stock are formed into a rigid linearly extending scrap element having opposite side walls and a base wall and a connected rigid linearly extending first spacer frame element having opposite side walls and a base wall. A connection between the scrap element and the first spacer frame element is then severed.
Patent HU-E031632-T2 (HU)
Title: Antigen binding molecules with increased Fc receptor binding affinity and effector function
Inventor: UMANA PABLO
IPC: C07K16/28
Filed: 2004-11-05
Abstract: The present invention relates to antigen binding molecules (ABMs). In particular embodiments, the present invention relates to recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human CD20. In addition, the present invention relates to nucleic acid molecules encoding such ABMs, and vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention, and to methods of using these ABMs in treatment of disease. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.
Patent HU-E024568-T2 (HU)
Title: N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridin yl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer
Inventor: PAYTON MARC
IPC: A61P35/02
Filed: 2010-09-09
Abstract: The present invention relates to methods of using the compound, N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine or a pharmaceutically acceptable salt thereof, to treat cancers, including solid tumors, which have become resistant to treatment with chemotherapeutic agents, including anti-mitotic agents such as taxanes, and/or other anti-cancer agents, including aurora kinase inhibiting agents. The invention also includes methods of treating cancers refractory to such treatments by administering a pharmaceutical composition, comprising the compound to a cancer subject.
Patent HU-E026088-T2 (HU)
Title: Container
Inventor: COPE ANDY
IPC: B65D21/06
Filed: 2011-01-07
Abstract: The present invention relates to a collapsible container comprising a pair of stacking members which, when the container is erect, are movable between a stacking position in which the stacking members are positioned to support the base of another container stacked thereon and a filling position in which the stacking members are substantially removed from the opening in the top of the container, and wherein the container further comprises a pair of releasable locking mechanisms, each of the releasable locking mechanisms operable to retain one wall of the first pair of opposed walls in an upstanding position and locked to both the walls of the second pair of walls when the walls of the second pair of walls are also in an upstanding position, and wherein the pair of releasable locking mechanisms are independent of the stacking members.
Patent HU-E034225-T2 (HU)
Title: Blanket with channels filled with substantially spherical objects for therapeutic treatment
Inventor: CHRISTIANSEN PIA RIISHOJ
IPC: A61H15/00
Filed: 2013-10-04
Abstract: The present invention relates to therapeutic blankets. More specifically, the invention relates to a therapeutic blanket with channels filled with replaceable weight bags for individualized therapeutic treatment.
Patent HU-E027454-T2 (HU)
Title: Fluid cartridge
Inventor: HARVEY DAVID C
Filed: 2010-10-22
Abstract: An ink cartridge (3) for an inkjet printer (2), comprising interfaces on the front face (33) for connection to a cartridge receiving structure (4), the interfaces including an ink socket (14) near a bottom face (35); a guide interface for guiding the cartridge (3) along a straight line (Y) for connecting the interfaces, the guide interface having a receiving opening (40) near the bottom face (35); a latch stop (30) and a latch track (28) in the bottom face (35) to guide and retain a latch (27) of the cartridge receiving structure (4); and an electrical circuit (10, 19) including a memory (11) comprising cartridge characteristics data, disposed near a top face (53) opposite to the bottom face (35), sunken in the front face (35) to make electrical contact after other interfaces are connected, the electrical circuit (10, 19) comprising electrodes that extend in a plane (Y, Z) perpendicular to the front face (33) and arranged on a line (PP) parallel to the front face (35) and behind the front face (35).
Patent MD-3649124-T2 (MD)
Inventor: NIROGI RAMAKRISHNA
IPC: C07D413/04
Filed: 2018-08-06
Abstract: Prezenta invenţie se referă la compuşi de fluoropiperidină cu formula (I), stereoizomerii, formele izotopice sau sărurile lor acceptabile farmaceutic ca antagonişti ai receptorilor de 5-Hidroxitriptamină 6 (5-HT6R). În mod specific, prezenta invenţie divulgă metodele de preparare, compoziţia farmaceutică, combinaţiile şi utilizarea compuşilor de fluoropiperidină, a stereoizomerilor, formelor izotopice sau sărurilor acceptabile farmaceutic ale acestora.
Patent TR-200100675-T2 (TR)
Title: Mikrokapsül formülasyonları.
Inventor: WOLF HILMAR
IPC: A01N25/28
Filed: 1999-08-24
Abstract: Asagidakilerden olusan yeni mikrokapsül formülasyonlari: A) asagidakileri içeren, taneciklerden olusan dagilmis bir faz: a) uygun oldugunda toluilen diizosiyanatla karisim halinde asagidaki formüle sahip izosiyanatin: (FORMÜL VAR) ve en azindan bir diamin, poliamin, dialkol, polialkol ve/veya aminoalkolün bir reaksiyon ürünü, b) özel bir madde grubundan seçilen tarim kimyasali olarak aktif en azindan bir bilesik ve c) uygun oldugunda katkilar, ve B) sivi sulu bir faz, bu formülasyonlarin hazirlanmasi için bir islem ve içerdikleri aktif bilesiklerin tatbik edilmesi için kullanilmalari.
Patent TR-200101891-T2 (TR)
Inventor: LINDRUD MARK D
IPC: C30B7/00
Filed: 2000-01-20
Abstract: A novel apparatus and process for crystallizing submicron-sized crystals of a pharmaceutical composition. The submicron-sized crystals, which have an average size of less than 1 micron, provide high surface area end product crystals with greatly improved stability and purity, and which afford crystals having improved bioavailability, higher dissolution, decreased decomposition rate and longer shelf-life.
Patent TR-200103825-T2 (TR)
Inventor: PELA PETER LAWRENCE
IPC: H01R29/00
Filed: 2000-04-05
Abstract: A system determines and monitors the connection pattern of data ports which are connected by multiconductor cables without requiring special patch cables or patch panels. An adapter jacket (7) having an external contact (8) is placed over a standardized cable (3) which connects the data ports. An adapter board (14) having a plurality of socket contacts (12) is placed adjacent a plurality of data ports. Output and input modules are coupled to the socket contacts (12). A microprocessor which is coupled to the output and input modules scans the socket contacts (12) to determine the connection pattern of the data ports.
Patent TR-200202463-T2 (TR)
Inventor: SCHOELKENS BERNWARD
IPC: A61P9/10
Filed: 2000-08-25
Abstract: Novel use of an inhibitor of the renin-angiotensin system or derivative (I) in the manufacture of a medicament for the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. Independent claims are also included for: a method of preventing of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF; and a formulation for use in the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. ACTIVITY : Cerebroprotective; Cardiant; Antidiabetic. Treating 9,541 patients who are at risk for cardiovascular events due to a history of previous ischemic heart disease, stroke, peripheral arterial disease or individuals with diabetes with ramipril for 6 years resulted in a 32% reduction in the number of patients who developed a stroke, 21% who developed congestive heart failure, and 36% reduction who developed diabetes. MECHANISM OF ACTION : Angiotensin converting enzyme (ACE) inhibitor; an angiotensin II antagonist.
Patent TR-200401834-T2 (TR)
Title: İntegrin hedefli görüntüleme etken maddeleri.
Inventor: WICKLINE A SAMUEL
IPC: A61K47/48
Filed: 2003-01-24
Abstract: Tercihen kaynama noktası yüksek sıvı perflorokimyasal maddelerden oluşturulmuş nanopartiküllerden müteşekkil emülsiyonlar, bir lipit/sürfektan kılıf ile kaplankış adı geçen maddeler, adı geçen nanopartiküllerin bir antikordan çok QvP3 integrinine özel liganta bağlanması suretiyle aktifleştirilmiş endotel hücrelerine özel bir hale getirilir. Nanopartiküller ayrıca biyolojik açıdan aktif ajanlar, radyonükleitler veya başka görüntüleme ajanları da içerebilirler.
Patent DE-602004004821-T2 (DE)
Inventor: MAAS C F
IPC: G06F3/0485
Filed: 2004-11-16
Granted: 2007-10-18
Abstract: A system ( 30 ) for displaying a subset of images from an image data set, in particular for medical applications such as MRI or CT scanning. The images are associated with three attributes with a respective range of values. The images on the display have values within a subrange of the respective range of values for two attributes and a value for the third attribute. The images are shown in a matrix. Each row of the matrix represents one value for the first attribute. Each column represents a value for the second attribute. All images on the display 34 have the same value for the third attribute. A user is enabled to scroll through the image data set by selecting other subranges for the first two attributes or by selecting another value for the third attribute of the images to display. The selecting of subranges is done by scrolling horizontal and vertical for the first and second attributes. The selecting of another value for a third attribute is done by scrolling substantially parallel to an imaginary z-axis.
Patent DE-602004004926-T2 (DE)
Inventor: CORDIER CHANTAL
IPC: G06V40/13
Filed: 2004-11-10
Granted: 2007-11-08
Abstract: A light source illuminates the finger through an optical plate (2), with the reflected light being propagated to the other end (B) which has an inclined end surface (8). A mirror and focussing lens (9) collect the rays of light emerging from the inclined end surface towards, forming a digital image of the fingerprint. The optical imaging system (1) for forming a digital image of a fingerprint comprises with a part (5) at one end (A) where the finger is to be placed. A light source illuminates the finger through the plate, with the reflected light being propagated with multiple reflections within the plate, alternately on each surface of the plate, to the other end (B) which has an inclined end surface (8). A focussing objective lens (9) faces this end plate with its axis situated in the median plane of the plate. A mirror (10) directs the rays of light emerging from the inclined end surface towards the objective lens along its axis.
Patent DE-602004010162-T2 (DE)
Inventor: XU FANG
IPC: G01R31/319
Filed: 2004-09-29
Granted: 2008-10-30
Abstract: A switching topology for communicating signals in an automatic test system includes a plurality of switching circuits each for selectively passing signals or crossing signals. Switching circuits are connected together such that each node of any switching circuit connects to no more than one node of any other switching circuit. This topology offers improved signal integrity, reduced cost, and reduced space as compared with conventional, matrix-style switching topologies.
Patent DE-69304072-T3 (DE)
Inventor: NYKANEN TUOMO S
IPC: D21C11/00
Filed: 1993-04-12
Granted: 2000-02-03
Abstract: Apparatus for a pulp and paper mill, and methods of acting on liquid effluents produced in the mill, which minimizes the discharge of polluting gaseous and liquid effluents to the environment. Liquid effluents from the bleach plant are concentrated (e.g. evaporated), incinerated (e.g. gasified), leached, crystallized (e.g. freeze crystallized) then washed, and then fed to the plant chemical recovery loop. White liquor produced from the recovery boiler melt is fully oxidized and used in place of caustic in the bleach plant. Essentially all sulfuric acid, sulfur dioxide, caustic, and chlorine dioxide necessary for the pulp mill is produced from mill liquid effluents and gas waste streams, on site at the pulp mill. Typical bleaching sequences that can be used are DEopDnD, or AZEo PZP.
Patent DE-69837760-T3 (DE)
Inventor: BLANK GREGORY
IPC: C07K1/36
Filed: 1998-06-12
Granted: 2012-06-21
Abstract: The invention herein provides a method for recovering a polypeptide comprising exposing a composition comprising a polypeptide to a reagent which binds to, or modifies, the polypeptide, wherein the reagent is immobilized on a solid phase; and then passing the composition through a filter bearing a charge which is opposite to the charge of the reagent in the composition, so as to remove leached reagent from the composition.
Patent DK-1065204-T3 (DK)
Inventor: HAYASHI SHIGEO
IPC: A61K31/403
Filed: 2000-06-26
Granted: 2002-07-22
Abstract: This invention provides a compound of the following formula:  <CHEM> or the pharmaceutically acceptable salts thereof wherein A is C 1-6alkylene or -NR<1>-; Z is C(=L)R<2>, or SO2R<3>; U is CH or N; W and Y are independently selected from - CH2-, O, S and -N-R<1>; m is 1, 2 or 3; q and r are independently 0, 1 or 2; X is independently selected from halogen, C 1-4alkyl, halo-substituted C 1-4 alkyl, hydroxy, C 1-4alkoxy, halo-substituted C 1-4 alkoxy or the like; n is 1 or 2; L is oxygen or sulfur; R<1> is hydrogen or C 1-4 alkyl; R<2> is hydroxy, C1-6alkyl, halo-substituted C 1-6 alkyl, C 1-6 alkoxy, halo-substitutued C 1-6 alkoxy, C 3-7 cycloalkoxy, C 1-4 alkyl(C 3-7 cycloalkoxy), -NR<4>R<5> or the like; R<3> is C 1-6 alkyl or halo-substituted C 1-6 alkyl; and R<4> and R<5> are independently selected from hydrogen, C 1-6alkyl and halo-substituted C 1-6alkyl. This invention also provides a pharmaceutical composition useful for the treatment of a medical condition in which prostaglandins are implicated as pathogens.
Patent DK-1057966-T3 (DK)
Inventor: BRUGGER KARL
IPC: E06B9/86
Filed: 2000-05-16
Granted: 2004-12-06
Abstract: The end rail (1), at a distance away from its two ends, is fixed to a winder-band (19), with a locking member each (13,14) tensioned by springs (16). When the end rail is in its lowest end position, it cooperates with a counter element (26) preventing the end rail from sliding upwards. Each winder band leads over a deflector element (23) fixed to the end rail. Both sides of the end rail are guided by sleeves (7) in vertical profiles (9). The locking elements comprise bolts sliding inside the sleeves.
Patent DK-1224233-T3 (DK)
Inventor: BARNES JAMES-MICHAEL
IPC: C08G18/10
Filed: 2000-08-11
Granted: 2004-02-09
Abstract: This invention relates to a process for producing prepolymers, which contain isocyanate terminal groups and which have a very low content of free isocyanate starting materials, from polyester polyols and polyisocyanates.
Patent DK-1227971-T3 (DK)
Inventor: BREIVIK KARE G
IPC: B63B27/30
Filed: 2000-10-26
Granted: 2004-12-06
Abstract: A system for transfer of liquefied natural gas (LNG) between two vessels (1, 2). The system comprises a coupling head (7) mounted at one end of a flexible pipe means (4) and arranged for attachment on a platform (19) at one end of one vessel (1) when it is not in use, and a connection unit (8) mounted at one end of the other vessel (2) and comprising a pull-in funnel (50) shaped for guided pull-in of the coupling head (7) to a locking position in which the pipe means (4) can be connected to transfer pipes (56) on the other vessel (2) via a valve means (31) arranged in the coupling head. The coupling head (7) is provided with a guide means (40) and is connected to at least one pull-in wire (42) for guided pull-in of the coupling head (7) into the connection unit (8) by a winch means (66) an the other vessel (2).
Patent DK-1157794-T3 (DK)
Inventor: JUNG ERHARD
IPC: B27G11/00
Filed: 2001-05-19
Granted: 2012-07-30
Abstract: The machine has a clamping/pressing unit, and a drive. The clamping unit (3) has two or more thrust pieces, which are charged independently of each other with a pressure force acting against the panel. The thrust pieces extend parallel to the timbers (2) forming the panels, and at right angles to the feed direction (8) of the panel. The thrust pieces have drives formed by piston-cylinder units (16b). The clamping unit has tubular heating elements (9), containing pref. a circuit of a flowing medium, pref. water, thermal oil, steam, etc.
Patent DK-1268361-T3 (DK)
Inventor: GOFFE BRUNO
IPC: C04B7/00
Filed: 2001-03-21
Granted: 2005-01-24
Abstract: The present invention concerns cementing compositions for an oil well or the like, based on a Portland cement, silica and alumina, wherein the mineralogical composition of the cement matrix is included in the Si-Ca-Al triangle in one of the margarite-haüyne-[epidote/pumpellyite], haüyne-prehnite-[epidote/pumpellyite] and haüyne-prehnite-pectolite composition triangles. More particularly, the cementing compositions of the invention are suitable for cementing wells subjected to high temperatures and to chemical attack by brines, and are more suitable when the brine-or a saline formulation close to that of the brine-is used as the mixing water.
Patent DK-1315502-T3 (DK)
Inventor: DUDLEY ROBERT E
IPC: A61P25/28
Filed: 2001-08-29
Granted: 2010-07-19
Abstract: The present invention relates to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a testosterone deficient disorder, or the symptoms associated with, or related to a testosterone deficient disorder in a female mammal in need thereof. The present invention also relates to a method of administering a steroid in the testosterone synthetic pathway, for example testosterone, to a mammal in need thereof. In addition, the methods, kits, combinations and compositions may be used in conjunction with other pharmaceutical agents effective at treating, preventing, or reducing the risk of developing a testosterone deficient disorder. The methods, kits, combinations and compositions can also be used in conjunction with a pharmacologically effective amount of an estrogenic hormone, for example, estradiol. Furthermore, the methods, kits, combinations and compositions can be used in conjunction with a pharmacologically effective amount of another steroid or pharmaceutical agent that increases serum testosterone levels in a mammal, for example, methyltestosterone.